# Carnitine and Liver Mitochondria Fatty Acid Processing

> **NCT03193125** · NA · COMPLETED · sponsor: **Pennington Biomedical Research Center** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Insulin Resistance
- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** L-Carnitine
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03193125
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2018-05-11
- **Final completion:** 2018-05-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03193125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03193125, "Carnitine and Liver Mitochondria Fatty Acid Processing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03193125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*